The paradigm shift is happening. New pharma target is same for Alzheimer's, Parkinson's, stroke, brain injury and MS. Proinflammatory cytokines are intiated in cerebral ischemia and hypoperfusion--related to blood flow.


New drug could treat Alzheimer's, multiple sclerosis and brain injury
www.sciencedaily.com
A new class of drug shows early promise of being a one-size-fits-all therapy for Alzheimer's, Parkinson's, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain. A new study reports when one of the new drugs is given to a mouse genetically engineered to develop Alzheime...